As insurers boost their private credit allocations, we propose a method for projecting cash flows without bespoke modeling.

Deeper discounts in the latest round of negotiated prices for Medicare Part D drugs may indicate how future negotiations will play out.

Ensemble-based unsupervised learning models offer promising alternatives to help carriers better manage anomaly detection in insurance data.